MARKET

ANNX

ANNX

Annexon, Inc.
NASDAQ
4.010
+0.370
+10.16%
After Hours: 4.010 0 0.00% 19:30 09/28 EDT
OPEN
3.850
PREV CLOSE
3.640
HIGH
4.080
LOW
3.735
VOLUME
5.07M
TURNOVER
--
52 WEEK HIGH
7.18
52 WEEK LOW
2.540
MARKET CAP
760.21M
P/E (TTM)
-3.4961
1D
5D
1M
3M
1Y
5Y
1D
Insider Spends US$100k Buying More Shares In Annexon
Simply Wall St · 1d ago
Annexon: Preserving Patient Function Is The Real Investment Opportunity
Seeking Alpha · 1d ago
Weekly Report: what happened at ANNX last week (0914-0918)?
Weekly Report · 09/21 10:16
Analysts Offer Insights on Healthcare Companies: Rocket Doctor AI (OtherAIRDF) and Annexon Biosciences (ANNX)
TipRanks · 09/16 09:01
Weekly Report: what happened at ANNX last week (0907-0911)?
Weekly Report · 09/14 10:21
Weekly Report: what happened at ANNX last week (0831-0904)?
Weekly Report · 09/07 10:14
Annexon Is Maintained at Overweight by JP Morgan
Dow Jones · 09/01 18:44
Annexon Price Target Raised to $14.00/Share From $10.00 by JP Morgan
Dow Jones · 09/01 18:44
More
About ANNX
Annexon, Inc. is a biopharmaceutical company advancing targeted immunotherapies aimed at complement-mediated neuroinflammatory diseases. It identifies and characterizes the role of the classical complement pathway in three therapeutic areas: autoimmune, neurodegeneration and ophthalmology. Tanruprubart is an investigational-targeted immunotherapy delivered in a single infusion to rapidly halt aggressive neuroinflammation and damage in GBS, an acute, rare, neuromuscular emergency. The Vonaprument is an investigational neuroprotective inhibitor of C1q and the classical complement cascade delivered intravitreally for dry AMD with GA, a leading cause of blindness. ANX1502, a novel oral small molecule for autoimmune conditions. The Company's next wave programs include ANX005 and ANX009. ANX009, a C1q-blocking Fab formulated for subcutaneous delivery, for patients with lupus nephritis.

Webull offers Annexon Inc stock information, including NASDAQ: ANNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANNX stock methods without spending real money on the virtual paper trading platform.